Wedbush reiterated their outperform rating on shares of Novadaq Technologies Inc. (TSE:NDQ) in a research note released on Thursday morning. The brokerage currently has a C$17.00 price objective on the stock.

Separately, Royal Bank Of Canada reiterated an outperform rating on shares of Novadaq Technologies in a research note on Thursday, July 7th.

Novadaq Technologies (TSE:NDQ) traded down 1.07% during mid-day trading on Thursday, hitting $14.77. 400 shares of the stock traded hands. The company’s market cap is $848.32 million. The firm’s 50-day moving average is $15.46 and its 200-day moving average is $13.98. Novadaq Technologies has a 12-month low of $10.81 and a 12-month high of $20.40.

Novadaq Technologies Company Profile

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Stock Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related stocks with our FREE daily email newsletter.